India Proposes Classifying Manipulated Cells And Tissue Products As Drugs
Executive SummaryThe Indian government is proposing to change the definition of a new drug to include substantially manipulated stem cell and tissue-based therapies.
You may also be interested in...
Draft update to national guidelines factors in additional safeguards and makes it mandatory to establish institutional panels to review stem cell research. Gene editing would be an area of "restrictive" research.
Whoever takes over as chair of the Medicines and Healthcare products Regulatory Agency will play a key role in its plans to deliver a program of “ambitious business change.”
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.